GCG and Glucose intolerance: Tissue-specific targeting could also be a relevant strategy, as illustrated by the protection conferred by a GLP-1–oestrogen conjugate against diet-induced obesity and glucose intolerance in mice via selective ERα activation in the CNS and the pancreas [64].